Cancer Research UK

• The Cancer Research UK Scotland Institute (formerly the Cancer Research UK Beatson Institute), which sits within the University of Glasgow and has ties to the Beatson West of Scotland Cancer Centre
• The Cancer Research UK Cambridge Institute, which sits within the University of Cambridge close to Addenbrooke's Hospital on the Cambridge Biomedical Campus.
• The Cancer Research UK Manchester Institute, formerly the Paterson Institute for Cancer Research, which sits within the University of Manchester and has ties to the Christie Hospital.[19][20]

• The Francis Crick Institute, with the Medical Research Council and the Wellcome Trust
• The Oxford Institute for Radiation Oncology, with the Medical Research Council
• The Gurdon Institute, with the Wellcome Trust
• The Manchester Cancer Research Centre, formed in 2006 by the University of Manchester, Cancer Research UK, and the Christie NHS Foundation Trust.[21]
• National Cancer Research Institute which also includes the Medical Research Council (UK) and Leukaemia & Lymphoma Research.[22]
• UK Department of Health, the Wellcome Trust, the National Health Service, NICE, and the Public Health England National Cancer Registration and Analysis Service.[23]

The charity participates in numerous citizen-science projects including:

• Cell Slider – its first project set up in 2012. Samples of breast cancer tumours, taken from earlier studies, were analysed through a web-based application.
• Play to Cure: Genes in Space – its first mobile game developed with Guerilla Tea, which originated as a prototype during a 48-hour game jam. Players plot routes to guide a spaceship in-game, which corresponds to analysis of genetic data.[24][25]
• Reverse the Odds – a mobile game based upon 'Play to Cure: Genes in Space' but with greater accuracy, involved completing puzzles and answering questions on lung and bladder cancer samples.
• The Impossible Line – a mobile puzzle game spotting genetic faults in breast cancer data, provided evidence that the game aspect lowered accuracy.
• Trailblazer – a web-based application looking at tissue samples identifying the presence or absence of cancer cells.[26]

The charity funds networks in seven locations across the UK, to drive collaborations between universities, NHS hospitals, and other research organisations. Centre status is awarded to locations performing the highest quality cancer research, to provide funds for equipment and training.[27] Centre status has been designated to:

• Cambridge: University of Cambridge
• City of London: Kings College London, University College London, Barts Cancer Institute, Francis Crick Institute
• Convergent Science: Imperial College London and the Institute of Cancer Research
• Manchester: University of Manchester
• Newcastle: Newcastle University
• Oxford: University of Oxford
• Scotland: University of Edinburgh and University of Glasgow

Drugs developed by the organization's scientists include:

• Cisplatin and carboplatin, cytotoxic chemotherapy drugs discovered at the Institute of Cancer Research in London.[28]
• Abiraterone, a prostate cancer drug discovered at the Institute of Cancer Research in London.[29]
• Temozolomide, which has an effect on glioblastoma, discovered by CRUK scientists at the University of Aston.[30]
• Rucaparib, a PARP inhibitor drug discovered by CRUK scientists including Ruth Plummer at the Northern Institute for Cancer Research .[31]
• Tamoxifen, a hormone therapy used to treat breast cancer and lower the risk of recurrence.[32]

Several of the organization's scientists have won major prizes, including:

• Tomas Lindahl: one of three recipients of the 2015 Nobel Prize in Chemistry, for mechanistic studies of DNA repair,[33][34] joined the organisation as a researcher in 1981, and from 1986 was the first Director of their Clare Hall research institute in Hertfordshire, since 2015 part of the Francis Crick Institute.
• Paul Nurse and Tim Hunt: recipients of the 2001 Nobel Prize in Physiology or Medicine, for work started at the London Research Institute.[35]
• Renato Dulbecco: recipient of the 1975 Nobel Prize in Physiology or Medicine, while deputy director of what was then the Imperial Cancer Research Fund.[36]

The “Cancer Research UK” logo is simple and unique. It forms an arrow shape which represents the fight against cancer. Further, the word “Cancer Research UK” is on the right while there is a cluster of same-size circles on the left side. All circles except one are in blue representing the community of cancer-affected people. One circle in pink at the tip represents hope. In summary, the logo of Cancer Research UK represents effort, strength, and hope against cancer.

There was a variation in the “Cancer Research UK” logo in 2012. Having clusters of different-sized circles with various colors ranging from grey to navy blue in a crescent shape represents a broader community of Cancer Research UK. Bold Upper case typography combines with the crescent shape to give it a unique look. The logo is a symbol of hope, strength, unity, and broader community.

There are two major changes in this logo. The cluster of circle organized more concisely, appears in motion, representing the continuous efforts of the organization against cancer. Typography changed from blue to dark black, representing the bold mission of the organization.

Through Cancer Health UK, a website written in Plain English, it provides information on cancer and cancer care, and a unique clinical trials database.[4] A team of nurses provides a confidential telephone service, the Cancer Chat forum provides a place for users to talk to others affected by cancer, and mobile cancer awareness units deliver health information to locations of high cancer incidence and mortality. It provides statistical information via the Cancer Stats section. It also provides publications for the public to order and download.

Cancer Research UK publishes a twice-monthly professional medical journal, the British Journal of Cancer.

The charity worked to bring about the smoking ban in England and continues to campaign for further action on smoking.[37] The charity lobbies for better screening programmes and advises on access to new cancer medicines.